Labeling of Disease-Modifying Therapies for Neurodegenerative Disorders

Labeling of Disease-Modifying Therapies for Neurodegenerative Disorders

Neurodegenerative disorders are characterized by progressive degeneration of nerve cells resulting in functional decline of cognition and/or movement. As the prevalence of many of these disorders increases with the aging global population, there is an urgent need for disease-modifying drugs that wil...

Full description

Bibliographic Details
Main Authors: Anne Vinther Morant, Vivien Jagalski, Henrik Tang Vestergaard
Format: Article
Language:English
Published: Frontiers Media S.A. 2019-10-01
Series:Frontiers in Medicine
Subjects:
disease modification
neurodegenerative disorders
label
indication
US Food and Drug Administration
European Medicines Agency
Online Access:https://www.frontiersin.org/article/10.3389/fmed.2019.00223/full

Internet

https://www.frontiersin.org/article/10.3389/fmed.2019.00223/full

Similar Items